Forward Looking Statements
This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "intends," "potential," "suggests" and similar expressions
are intended to identify forward-looking statements. These statements are based on Phio Pharmaceuticals Corp.'s (the "Company") current beliefs and expectations. Such statements include, but are not limited to, statements about the impact to our business and operations by the ongoing coronavirus pandemic, the development of our product candidates, the expected timing of certain developmental milestones (including timing or likelihood of regulatory filings and approvals), results from our preclinical and clinical studies, potential partnership opportunities, and the success of any such opportunities, the Company's competition and market opportunity and pro forma estimates. The inclusion of forward-looking statements should not be regarded as a representation by the Company that any of its plans will be achieved. Actual results may differ from those set forth in this presentation due to risks and uncertainties in the Company's business, including those identified under "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K and in other filings the Company periodically makes with the U.S. Securities and Exchange Commission. The Company does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.